Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States
- 24 June 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 29 (29-30), 4739-4744
- https://doi.org/10.1016/j.vaccine.2011.04.092
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal DiseaseClinical Infectious Diseases, 2010
- Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcusVaccine, 2009
- Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidisPublished by Elsevier BV ,2009
- Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal diseaseVaccine, 2009
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences of the United States of America, 2006
- Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup BVaccine, 2005
- NadA Diversity and Carriage in Neisseria meningitidisInfection and Immunity, 2004
- Vaccine Potential of theNeisseria meningitidis2086 LipoproteinInfection and Immunity, 2004
- NadA, a Novel Vaccine Candidate of Neisseria meningitidis The Journal of Experimental Medicine, 2002
- Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome SequencingScience, 2000